Zeher Margit, Horvath Ildiko Fanny, Szanto Antonia, Szodoray Peter
Division of Clinical Immunology, Medical and Health Science Center, University of Debrecen , Debrecen, Hungary.
Thyroid. 2009 Jan;19(1):39-45. doi: 10.1089/thy.2007.0398.
Previous studies on relatively small populations of patients with primary Sjögren's syndrome (pSS) suggested an association between pSS and Hashimoto's thyroiditis (HT). As some findings in the literature regarding the relationship between pSS and thyroid disease are contradictory, and there is little information on the sequence of pSS and HT, we conducted a study with a population of patients with pSS that was about three times larger than previously studied populations. Our objective was to determine the prevalence of HT and Graves' disease (GD) in patients with pSS and to assess the sequence of pSS and autoimmune thyroid diseases.
A total of 479 patients with pSS were retrospectively studied. Thyroid ultrasound and scintigraphy were performed, and serum thyrotropin, free triiodothyronine, free thyroxine, antithyroid peroxidase antibody (TPOAb), and anti-thyroglobulin autoantibody (TgAb) measurements were carried out. Solitary thyroid nodules were investigated by fine-needle aspiration biopsy.
Thyroid dysfunction was found in 95 patients (21.25%). Thirty of these patients had HT and 18 had GD. HT predated pSS in eight patients, developed at approximately the same time in seven patients, and followed pSS in 15 patients. Almost all (90%) patients with HT had persistently elevated serum TgAb or TPOAb titers.
An association between HT and pSS was found based on the fact that the frequency of HT was greater among pSS patients (6.26%) than in the general population (1-2%). In contrast, no association between GD and pSS was found. We noted that both HT and GD can appear either before or after the onset of pSS. Since most cases of pSS predate the appearance of autoimmune thyroid diseases it is important to determine if pSS is a predisposing factor for the development of autoimmune thyroiditis.
先前针对相对少量原发性干燥综合征(pSS)患者群体的研究提示pSS与桥本甲状腺炎(HT)之间存在关联。由于文献中关于pSS与甲状腺疾病关系的一些发现相互矛盾,且关于pSS和HT发生顺序的信息较少,我们开展了一项研究,研究对象为pSS患者群体,其规模约为先前研究群体的三倍。我们的目的是确定pSS患者中HT和格雷夫斯病(GD)的患病率,并评估pSS与自身免疫性甲状腺疾病的发生顺序。
对479例pSS患者进行回顾性研究。进行了甲状腺超声和闪烁扫描检查,并测定了血清促甲状腺激素、游离三碘甲状腺原氨酸、游离甲状腺素、抗甲状腺过氧化物酶抗体(TPOAb)和抗甲状腺球蛋白自身抗体(TgAb)。通过细针穿刺活检对孤立性甲状腺结节进行检查。
95例患者(21.25%)存在甲状腺功能障碍。其中30例患者患有HT,18例患有GD。8例患者HT先于pSS出现,7例患者HT与pSS大致同时出现,15例患者HT在pSS之后出现。几乎所有(90%)HT患者的血清TgAb或TPOAb滴度持续升高。
基于HT在pSS患者中的发生率(6.26%)高于普通人群(1 - 2%)这一事实,发现了HT与pSS之间存在关联。相比之下,未发现GD与pSS之间存在关联。我们注意到HT和GD均可在pSS发病之前或之后出现。由于大多数pSS病例早于自身免疫性甲状腺疾病出现,确定pSS是否为自身免疫性甲状腺炎发生的诱发因素很重要。